Patients with the chronic inflammatory bowel disease ulcerative colitis might reduce their risk of a relapse by having their appendix removed, a new stu ...

Following the study, the FDA approved the use of Tremfya to treat moderately to severely active ulcerative colitis. In September 2024, the University of Chicago Medicine became the first hospital in ...

The University of Central Lancashire is co-leading the first and largest human trial of its kind. A study found that patients with mild-to-moderate ulcerative colitis who drank 130ml of diluted Montmo ...

Ulcerative colitis (UC) is a chronic, long-term medical condition. It's a type of inflammatory bowel disease (IBD). UC can cause inflammation and ulcers in the lining of your colon (large ...

The following is a summary of "Bronchiectasis In Patients With Inflammatory Bowel Diseases – Prevalence, Predictors, And ...

The FDA has accepted Yuflyma as an interchangeable biosimilar to adalimumab for the treatment of multiple chronic ...

A recent study from Bulgaria suggests that low levels of vitamin D may be connected to more severe cases of inflammatory ...

OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025 New Clinical Data from Phase 2 Extension ...